跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
Establishment and characterization of a rectal cancer model in mice: Application to cytokine gene therapy
Yun Chen, King Jen Chang,
Lih Hwa Hwang
, Chiung Nien Chen, Sheng Hong Tseng
*
*
此作品的通信作者
微生物及免疫學研究所
研究成果
:
Article
›
同行評審
6
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Establishment and characterization of a rectal cancer model in mice: Application to cytokine gene therapy」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Colorectal Cancer
100%
Cancer Model
100%
Cytokine Gene Therapy
100%
Granulocyte Colony-stimulating Factor (G-CSF)
60%
Therapeutic Vaccine
60%
Rectal Tumor
60%
Tumor Cells
40%
Antitumor Effect
40%
Rectum
40%
Orthotopic Model
40%
Complementary DNA (cDNA)
20%
Survival Time
20%
CT-26 Cells
20%
Tumor Growth
20%
Reimplantation
20%
CT26
20%
Colorectal Adenocarcinoma Cells
20%
Therapeutic Effect
20%
Mean Survival Time
20%
Small Tumor
20%
Tumor Implantation
20%
Retroviral Vector
20%
Submucosa
20%
Two-dose
20%
Tumor Growth Rate
20%
Medicine and Dentistry
Cytokine
100%
Gene Therapy
100%
Cancer Model
100%
Rectum Cancer
100%
Granulocyte Macrophage Colony Stimulating Factor
60%
Rectum Tumor
60%
Tumor Vaccine
60%
Tumor Progression
40%
Survival Time
40%
Cell Line
20%
Immunotherapy
20%
Neoplasm
20%
Tumor Cell
20%
Metastatic Carcinoma
20%
Complementary DNA
20%
Therapy Effect
20%
Submucosa
20%
Replantation
20%
Retrovirus Vector
20%
Tumor Cell Inoculation
20%
Colon Adenocarcinoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Cancer Model
100%
Rectum Cancer
100%
Neoplasm
60%
Granulocyte Macrophage Colony Stimulating Factor
60%
Tumor Vaccine
60%
Rectum Tumor
60%
Survival Time
40%
Tumor Growth
40%
Immunotherapy
20%
Complementary DNA
20%
Metastasis
20%
Colon Adenocarcinoma
20%
Therapeutic Effect
20%
Retrovirus Vector
20%
Immunology and Microbiology
Cytokine
100%
Granulocyte Macrophage Colony-Stimulating Factor
100%
Tumor Vaccine
100%
Tumor Cell
66%
Survival Time
66%
Rectum
66%
Immunotherapy
33%
Wild Type
33%
Colon
33%
Cell Line
33%
Retrovirus Vector
33%
Submucosa
33%
Tumor Cell Inoculation
33%